药品注册申请号:017624
申请类型:NDA (新药申请)
申请人:BAXTER HLTHCARE
申请人全名:BAXTER HEALTHCARE CORP
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 FORANE ISOFLURANE LIQUID;INHALATION 99.9% Yes Yes AN 1979/12/18 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/12/09 SUPPL-43(补充) Approval Labeling STANDARD
2022/11/01 SUPPL-42(补充) Approval Labeling STANDARD
2021/10/25 SUPPL-40(补充) Approval Labeling STANDARD
2017/04/27 SUPPL-41(补充) Approval Labeling STANDARD
2013/02/21 SUPPL-39(补充) Approval Manufacturing (CMC) PRIORITY
2010/02/22 SUPPL-36(补充) Approval Labeling UNKNOWN
2006/08/31 SUPPL-34(补充) Approval Labeling STANDARD
2002/09/27 SUPPL-32(补充) Approval Manufacturing (CMC) PRIORITY
2000/12/01 SUPPL-31(补充) Approval Manufacturing (CMC) PRIORITY
1999/07/23 SUPPL-30(补充) Approval Manufacturing (CMC) PRIORITY
1999/05/14 SUPPL-29(补充) Approval Labeling STANDARD
1998/12/09 SUPPL-28(补充) Approval Manufacturing (CMC) PRIORITY
1997/02/26 SUPPL-27(补充) Approval Manufacturing (CMC) PRIORITY
1996/07/01 SUPPL-25(补充) Approval Manufacturing (CMC) PRIORITY
1996/02/09 SUPPL-24(补充) Approval Manufacturing (CMC) PRIORITY
1995/07/05 SUPPL-23(补充) Approval Labeling STANDARD
1990/01/16 SUPPL-19(补充) Approval Labeling
1987/02/25 SUPPL-18(补充) Approval Manufacturing (CMC) PRIORITY
1986/04/16 SUPPL-17(补充) Approval Manufacturing (CMC) PRIORITY
1986/04/16 SUPPL-16(补充) Approval Labeling
1986/04/16 SUPPL-15(补充) Approval Labeling
1985/10/17 SUPPL-14(补充) Approval Labeling
1985/08/02 SUPPL-12(补充) Approval Manufacturing (CMC) PRIORITY
1985/03/15 SUPPL-13(补充) Approval Labeling
1984/11/20 SUPPL-11(补充) Approval Manufacturing (CMC) PRIORITY
1984/06/12 SUPPL-8(补充) Approval Labeling
1983/04/01 SUPPL-10(补充) Approval Labeling
1983/02/09 SUPPL-9(补充) Approval Manufacturing (CMC) PRIORITY
1982/07/01 SUPPL-2(补充) Approval Labeling
1982/02/22 SUPPL-7(补充) Approval Efficacy
1981/09/29 SUPPL-6(补充) Approval Manufacturing (CMC) PRIORITY
1981/06/05 SUPPL-5(补充) Approval Manufacturing (CMC) PRIORITY
1981/05/26 SUPPL-4(补充) Approval Labeling
1981/05/26 SUPPL-3(补充) Approval Manufacturing (CMC) PRIORITY
1981/05/26 SUPPL-1(补充) Approval Manufacturing (CMC) PRIORITY
1979/12/18 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ISOFLURANE 剂型/给药途径:LIQUID;INHALATION 规格:99.9% 治疗等效代码:AN
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
017624 001 NDA FORANE ISOFLURANE LIQUID;INHALATION 99.9% Prescription Yes Yes AN Approved Prior to Jan 1, 1982 BAXTER HLTHCARE
074416 001 ANDA ISOFLURANE ISOFLURANE LIQUID;INHALATION 99.9% Prescription No No AN 1994/09/30 PIRAMAL CRITICAL
074502 001 ANDA ISOFLURANE ISOFLURANE LIQUID;INHALATION 99.9% Prescription No No AN 1995/06/27 PIRAMAL PHARMA
075225 001 ANDA ISOFLURANE ISOFLURANE LIQUID;INHALATION 99.9% Prescription No No AN 1999/10/20 HALOCARBON PRODS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database